Key result
Ziprasidone treatment was associated with pronounced QTc interval prolongation, with two out of three cases showing values exceeding 0.50 seconds.
Why the study?
Does ziprasidone treatment cause QTc interval prolongation?
Case Report (n=3)
Does ziprasidone treatment cause QTc interval prolongation?
Ziprasidone treatment may be associated with pronounced QTc interval prolongation exceeding 0.50 s in some patients.
Answers are grounded in this paper and cite their sources.
Supports QTc monitoring with ziprasidone; hypothesis-generating pending larger prospective studies.
QTc interval prolongation may appear as a consequence of both typical and atypical antipsychotic treatments. Ziprasidone, which is effective in treating schizophrenia, is associated with QTc prolongation. Although the prolongation of QTc with ziprasidone treatment is often pronounced, there is a scarce number of cases reported about the relationship between ziprasidone and QTc prolongation. Of the three cases presented in this case series, two cases showed values exceeding 0.50 s with ziprasidone treatment.
No takes yet. Share an insight, caveat, or question.
Eker et al. (2008) conducted a case report in Schizophrenia (n=3). Ziprasidone was evaluated on QTc interval exceeding 0.50 seconds. Ziprasidone treatment was associated with pronounced QTc interval prolongation, with two out of three cases showing values exceeding 0.50 seconds.
Synapse has enriched 10 related papers. Consider them for comparative context: